Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Non-Current Liabilities (2022 - 2025)

PAVmed has reported Total Non-Current Liabilities over the past 4 years, most recently at $927000.0 for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 48.5% year-over-year to $927000.0; the TTM value through Dec 2025 reached $927000.0, down 48.5%, while the annual FY2025 figure was $927000.0, 48.5% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $927000.0 at PAVmed, down from $1.2 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $57.6 million in Q3 2023 and troughed at $927000.0 in Q4 2025.
  • A 4-year average of $13.6 million and a median of $2.0 million in 2022 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 2385.25% in 2023 and later tumbled 86.09% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $2.2 million in 2022, then soared by 492.62% to $12.9 million in 2023, then tumbled by 86.09% to $1.8 million in 2024, then tumbled by 48.5% to $927000.0 in 2025.
  • Business Quant data shows Total Non-Current Liabilities for PAVM at $927000.0 in Q4 2025, $1.2 million in Q3 2025, and $1.4 million in Q2 2025.